BNY Mellon, Citi Ventures , Visa and Poste Italiane subsidiary PostePay all contributed to the first funding round to be disclosed by the payment software provider.

Existing investor Hikma Ventures returned for a series B round that came amidst increased demand for Lemonaid's remote healthcare services.

Biocon's biosimilar subsidiary is valued at $3.5bn in the deal, which will involve Tata Capital acquiring a stake sized at under 1%.

Backed by Cambria Health Solutions and Link-Age, True Link has now raised $50m in all to provide financial services geared toward vulnerable groups.

Ford Smart Mobility and JetBlue Technology Ventures-backed ClimaCell will put the series C capital towards R&D and commercialisation activities.

Stanford-StartX Fund has backed the electronics manufacturing management software developer, with the proceeds going to product development.

Drug protein discovery company Bright Peak hopes to deliver conjugated cancer immunotherapies based on an ETH Zürich-invented platform.

SmartX, a data storage virtualisation business that counts Samsung and Lenovo as shareholders, has announced series B-plus and C funding to expand its product offering.

Enthera Pharmaceuticals was co-founded by faculty from University of Milan and is using stem cells to treat autoimmune disorders.

IU Philanthropic Venture Fund returned for a series A round expected to help MBX identify clinical-stage peptides for rare endocrine genetic diseases.